Disulfidptosis-Associated CCNB2: A Prognostic Biomarker and Immune Microenvironment Modulator in Prostate Cancer
Journal of Cancer · 03.09.2025 · 16 (13) · 3928-3941
DOI: 10.7150/jca.112791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer, erschienen am 03.09.2025. Verfasst von Wei Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tongji Hospital, Affiliated with Tongji University, Shanghai, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tongji Hospital, Affiliated with Tongji University, Shanghai, China.
Zitieren
APA
Jiang, W., Wang, Q., Zhou, J., Zhao, Y., Qin, X., Li, X., Li, H., Wang, L., & Wu, G. (2025). Disulfidptosis-Associated CCNB2: A Prognostic Biomarker and Immune Microenvironment Modulator in Prostate Cancer. Journal of Cancer, 16(13), 3928-3941. https://doi.org/10.7150/jca.112791
Vancouver
Jiang W, Wang Q, Zhou J, Zhao Y, Qin X, Li X, et al. Disulfidptosis-Associated CCNB2: A Prognostic Biomarker and Immune Microenvironment Modulator in Prostate Cancer. Journal of Cancer. 2025;16(13):3928-3941. doi:10.7150/jca.112791
BibTeX
@article{Jiang2025,
author = {Jiang, Wei and Wang, Qinghua and Zhou, Juan and Zhao, Yan and Qin, Xin and Li, Xilei and Li, Haopeng and Wang, Licheng and Wu, Gang},
title = {Disulfidptosis-Associated CCNB2: A Prognostic Biomarker and Immune Microenvironment Modulator in Prostate Cancer},
journal = {Journal of Cancer},
year = {2025},
volume = {16},
number = {13},
pages = {3928--3941},
doi = {10.7150/jca.112791}
}
EUVIMED